Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leymus condensatus pollen is an allergen extract derived from the pollen of *Leymus condensatus*, commonly known as giant wildrye, a perennial grass native to the western United States and northern Mexico. This biological product is used primarily as a diagnostic tool in allergy testing, such as skin prick tests or in vitro IgE assays, to identify individuals with hypersensitivity to this specific grass species. The extract contains allergenic proteins that, upon exposure in sensitized individuals, cross-link specific IgE antibodies on the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine. This reaction allows clinicians to diagnose allergic rhinitis, conjunctivitis, or asthma associated with giant wildrye pollen exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on leymus condensatus pollen.